Natera Inc. is a diagnostics and research company that specializes in proprietary molecular and bioinformatics technologies. Its primary products include Panorama, a non-invasive prenatal testing (NIPT) solution designed to screen for chromosomal abnormalities in fetuses and twins, typically through a blood draw from the mother; Horizon Carrier Screening (HCS), which identifies carrier status for a range of severe genetic disorders that could be passed on to children; Signatera, a molecular residual disease (MRD) test that detects circulating tumor DNA in patients previously diagnosed with cancer, allowing for the assessment of molecular residual disease and monitoring for recurrence; and Prospera, a test that evaluates organ transplant rejection.

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for NTRA via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.